Back to Clinical Trials
N/ARecruiting

Sleep Promotion and Pediatric Hypertension

Sponsored by Children's Hospital of Philadelphia

About this study

Determine the effectiveness and feasibility of a mobile health sleep extension approach in the pediatric nephrology setting, to increase sleep duration and reduce systolic and diastolic blood pressure.

Insufficient sleep is associated with hypertension in children. Despite this knowledge, sleep promotion is not considered as a behavioral target during the initial treatment of pediatric essential hypertension. Investigators are developing a mobile platform to promote sleep in children that may have utility for treating pediatric essential hypertension. The overall objective of this study is to determine the effectiveness and feasibility of a mobile health sleep extension approach in the pediatric nephrology setting, to increase sleep duration and reduce systolic and diastolic blood pressure. This is a home-based, single-site study, of 13-to-18-year-olds (N=10, 5 parent-child dyads). Participants will have a recent diagnosis of essential hypertension, based on clinical ambulatory blood p…

Where this study is enrolling

  • Children's Hospital of Philadelphia

    Philadelphia, Pennsylvania

    I'm interested
Who can participate

Inclusion criteria

  • ✓Speak, read and write in English.
  • ✓Parental/guardian permission (informed consent) and child assent.
  • ✓Have a computer or a tablet computer with access to the Internet or own a smartphone with a data and text plan.
  • ✓Parent reported sleep duration on school nights less than or equal to 7.5 hours.
  • ✓Recently diagnosed with essential hypertension by Ambulatory Blood Pressure Monitoring (ABPM).
  • ✓If taking over the counter sleep aides, willing to stop them over the course of the study.

Exclusion criteria

  • ✕Any clinically diagnosed sleep disorder (e.g. sleep apnea) in the electronic health record and or regular use of prescribed sleep aide.
  • ✕Underlying chronic medical conditions, defined as a medical condition with a duration or expected duration longer than 3 months that involved taking regular medication, taking medications that could affect blood pressure (e.g., anti-hypertensive medications, glucocorticoids, or stimulants), and patients with underlying diagnoses known to be associated with elevated blood pressure (e.g., cardiac disease, kidney disease or diabetes).
  • ✕Inclusion Criteria for Parents/Legal Guardians:
  • ✕Be the parent/guardian of an eligible child enrolled in the main study.
  • ✕Speak, read, and write in English.
  • ✕Exclusion Criteria for Parents/Legal Guardians:
  • ✕\- Limited English proficiency

Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.

Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.

Trial data sourced from ClinicalTrials.gov.